Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Long-Term Investments: 2021-2023

Historic Long-Term Investments for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $27.0 million.

  • ADC Therapeutics' Long-Term Investments fell 22.19% to $27.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $27.0 million, marking a year-over-year decrease of 22.19%. This contributed to the annual value of $7.6 million for FY2022, which is 81.54% down from last year.
  • Latest data reveals that ADC Therapeutics reported Long-Term Investments of $27.0 million as of Q3 2023, which was down 4.71% from $28.3 million recorded in Q2 2023.
  • ADC Therapeutics' Long-Term Investments' 5-year high stood at $47.4 million during Q1 2021, with a 5-year trough of $7.6 million in Q4 2022.
  • Its 3-year average for Long-Term Investments is $34.7 million, with a median of $36.8 million in 2022.
  • Data for ADC Therapeutics' Long-Term Investments shows a maximum YoY tumbled of 81.54% (in 2022) over the last 5 years.
  • Quarterly analysis of 3 years shows ADC Therapeutics' Long-Term Investments stood at $41.2 million in 2021, then plummeted by 81.54% to $7.6 million in 2022, then fell by 22.19% to $27.0 million in 2023.
  • Its Long-Term Investments was $27.0 million in Q3 2023, compared to $28.3 million in Q2 2023 and $29.5 million in Q1 2023.